Finance

Lists
Why is ACTU down 10.77%?
Dive Deeper
ACTU:NASDAQ
Actuate Therapeutics Inc
$0.72
-10.77%
(-0.087) 1D
$0.68
-5.52% (-0.040)
After hours
Closed: Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACTU...
Open
$0.64
High
$0.72
Low
$0.62
Mkt. cap
17.43M
Avg. vol.
399.53K
Volume
637.89K
52-wk high
$8.49
52-wk low
$0.60
EPS
-$0.89
Shares outstanding
24.01M
No. of employees
12
Open
$0.64
High
$0.72
Low
$0.62
Mkt. cap
17.43M
Avg. vol.
399.53K
Volume
637.89K
52-wk high
$8.49
52-wk low
$0.60
EPS
-$0.89
Shares outstanding
24.01M
No. of employees
12
News stories
From web sources and news partners
About Actuate Therapeutics Inc
CEO-
Employees12
Founded2015
HeadquartersFort Worth, Texas, United States
SectorBiotechnology
Websiteactuatetherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to ACTU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ACTU in the last 3 months.
Highest
Current $0.72
$15.00 (+1,971.25%)
Average
$10.50 (+1,349.88%)
Lowest
$6.00 (+728.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$15.00
+1,971.3%
09/21/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$6.00
+728.5%
07/30/2026
Christopher Liu
Lucid Capital
Buy
Maintained
$5.00
+590.4%
05/18/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$12.00
+1,557%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.18M
2.13M
2.57M
2.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.29M
2.56M
3.14M
2.84M
Operating expense
5.47M
4.69M
5.71M
4.91M
Total operating expenses
5.47M
4.69M
5.71M
4.91M
Operating income
-5.47M
-4.69M
-5.71M
-4.91M
Other non operating income
-
-
-
-
EBT including unusual items
-5.41M
-4.55M
-5.63M
-4.87M
EBT excluding unusual items
-5.41M
-4.55M
-5.63M
-4.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.41M
-4.55M
-5.63M
-4.87M
Net profit margin
-
-
-
-
Earnings per share
-0.25
-0.18
-0.24
-0.20
Interest and investment income
69.97K
139.58K
85.27K
45.02K
Interest expense
-5.06K
-5.06K
-5.06K
-5.06K
Net interest expenses
64.91K
134.52K
80.21K
39.95K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps